liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Increased expression of proteins in CHO cells by identification of signal peptides for improved secretion of translated proteins
Linköping University, Department of Physics, Chemistry and Biology, Biotechnology.
2018 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Main purpose of this study was to increase protein expression in Chinese hamster ovary (CHO) cells by improving protein secretion of translated proteins. The goal was to find signal peptides from the screening of signal peptide libraries for improvement of protein secretion using a CHO-cell express selection system.

Biopharmaceutical products, proteins such as monoclonal antibodies (mAbs), are most commonly produced using mammalian expression systems such as the expression in CHO cells. The posttranslational modifications of the proteins being expressed in CHO cells are similar to the expressional modifications in human cells, why the CHO cells are suitable for production of proteins used for human therapy. The expression of proteins in the cell is a complex mechanism, fundamentally depending on the DNA sequences in the cell nucleus. Secretion of translated proteins has been showed to be a bottleneck when improving expression. Secretion is initiated by the signal peptide, a n-terminal prolongation of the protein that is recognized by a signal recognition particle (SRP) when being translated by the ribosome. The sequence and structure of the signal peptide has been proved to affect secretion and altering the signal peptide could improve secretion even when changing signal peptide between different species. Designing variants of the signal peptides and analyzing protein expression might lead to improvements of the construct design and more protein produced from the cells, which would save time, money and material for the producer.

To construct plasmids containing the gene of interest (GOI) and different signal peptides, several gene cloning methods were used. The plasmids were amplified using Escherichia coli (E. coli) transformation. The constructs were expressed by transfection into the CHO cell genome, and expression were analyzed using flow cytometry.

When analyzing expression of a Fc-fusion protein with 5 different signal peptides, the signal peptide Azurocidin is the one showing highest expression levels in this study. In addition, IgG kapa and Albumin signal peptides did not show as high protein expression levels, even if they were better than the L1d and H5b signal peptides. Since signal peptides are exchangeable between proteins and species, it might be that Azurocidin is improving secretion and protein expression with other proteins than Fc-fusion proteins which would be an interesting aspect for further studies.

When altering signal peptides with library sequences, the experimental challenges were crucial for the protein expression results and due to these issues, no library sequence could be seen to conquer others when it comes to protein expression levels. Transfection and cultivation procedures needs to be studied and improved before being able to draw conclusions about which signal peptide library sequences that might improve secretion and increase the protein expression.

Place, publisher, year, edition, pages
2018. , p. 44
Keywords [en]
Chinese hamster ovary, signal peptide, protein expression, plasmid, library, gene, Fc-fusion, monoclonal antibody, E. coli, flow cytometry, transfection, transformation
National Category
Industrial Biotechnology
Identifiers
URN: urn:nbn:se:liu:diva-150364ISRN: LITH-IFM-A-EX--18/3494--SEOAI: oai:DiVA.org:liu-150364DiVA, id: diva2:1240110
External cooperation
GE Healthcare Bio-Sciences AB
Subject / course
Biotechnology
Presentation
2018-06-08, Jordan/Fermi, Fysikhuset, 581 83 Linköping, Linköping, 14:15 (Swedish)
Supervisors
Examiners
Available from: 2018-08-23 Created: 2018-08-20 Last updated: 2018-08-23Bibliographically approved

Open Access in DiVA

fulltext(2665 kB)366 downloads
File information
File name FULLTEXT01.pdfFile size 2665 kBChecksum SHA-512
9c53ea7f5921c50359aa791bd29021bc6181e887f53e932a316d6c8f164adc3e8ad768453d0f43e9645ef2a7794a141f93bd4311b4ac9bfd66212bf3b3988a7e
Type fulltextMimetype application/pdf

Search in DiVA

By author/editor
Strannermyr, Malin
By organisation
Biotechnology
Industrial Biotechnology

Search outside of DiVA

GoogleGoogle Scholar
Total: 366 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 465 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf